Le Lézard
Classified in: Science and technology, Business
Subject: AWD

OutSolve Receives Prestigious Award at the 2024 Riverside Leadership Summit


OutSolve has received the Riverside Summit Award at the 2024 Leadership Summit signifying the company's remarkable growth and operational excellence

METAIRIE, La., April 16, 2024 /PRNewswire-PRWeb/ -- OutSolve, a leading provider of employment compliance solutions, is proud to announce it has been honored with the prestigious Summit Award given by The Riverside Company, a global private equity investment firm. This accolade is reserved for portfolio companies within the Riverside Capital Appreciation Fund (RCAF) that have not only excelled during their partnership with Riverside, but have also navigated through challenges with exceptional resilience and determination. The award was presented at this year's 2024 Riverside Leadership Summit in Orlando, FL.

The Summit Award is a testament to OutSolve's achievements and the fruitful partnership with The Riverside Company. It marks a significant milestone in OutSolve's journey and sets a promising trajectory for its future endeavors.

Since partnering with Riverside in 2022, OutSolve has demonstrated remarkable growth and operational excellence. As a testament to its strategic vision and execution capabilities, OutSolve has completed four significant acquisitions, expanding its offerings and market reach. Furthermore, the company has achieved a remarkable 34% increase in sales, a 20% rise in EBITDA, and a 37% surge in overall value. These accomplishments underscore OutSolve's commitment to stellar performance and its pivotal role in helping companies navigate the ever-changing and increasingly stringent regulatory landscape across various states and federal agencies.

"OutSolve is proud of this Riverside Summit Award," said Jeremy Mancheski, Founder and CEO of OutSolve. "This award is emblematic of the exceptional performance of the entire OutSolve team along with the support we receive from Riverside. The achievements to date are a direct result of OutSolve's innovative approach, customer-centric focus, and relentless pursuit of growth."

The Summit Award is a testament to OutSolve's achievements and the fruitful partnership with The Riverside Company. It marks a significant milestone in OutSolve's journey and sets a promising trajectory for its future endeavors.

Founded in 1998, OutSolve specializes in providing comprehensive labor and employment compliance solutions. Catering to over 3,200 clients across diverse industries throughout the United States, the Company is dedicated to promoting fair workplace practices by ensuring businesses stay ahead of regulatory requirements.

About OutSolve

OutSolve is a leading affirmative action consulting firm dedicated to helping companies comply with Office of Federal Contractor Compliance Programs' (OFCCP) regulatory requirements. We specialize in complete affirmative action plan preparation, OFCCP audit support, diversity, equity, and inclusion, pay equity analysis, and EEO-1/VETs reporting. We understand that as the workplace evolves, compliance initiatives must change with it. Our services are more than check-the-box support, we offer solutions that help companies demonstrate tangible actions.

About The Riverside Company

The Riverside Company, established in 1988 and based in New York, New York, is renowned for its strategic investments in growth-stage companies. By leveraging its extensive expertise and resources, Riverside seeks to drive transformational growth in its portfolio companies across a wide range of sectors, including business services, consumer products, healthcare, and technology, among others.

Media Contact

Mary Madden, OutSolve, 1 504.486.2410, [email protected], https://www.outsolve.com/

SOURCE OutSolve


These press releases may also interest you

at 21:03
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:44
Alerian MLP ETF (the "Fund" or "AMLP") has modified the estimate of the Fund's deferred tax liability based on information reported by the Master Limited Partnerships (MLPs) and recorded an additional tax accrual of approximately $32.1 million...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 20:00
Chainstack, a frontrunner among the top three global Web3 infrastructure providers, has successfully secured a strategic investment from SBI Ven Capital, Sygnum, Azimut Group, Unicorn Factory Ventures, and Ventech Ventures. This investment will...



News published on and distributed by: